Skip to main content

Table 2 Clinical features of patients with RDD mimic IgG4-RD, RDD or IgG4-RD

From: Rosai–Dorfman disease mimicking IgG4-related diseases: a single-center experience in China

  RDD mimic IgG4-RD (%) RDD (%) RDD total (%) IgG4-RD (%) p valuea
Age (years) 56(29–63) 52.5(28–81) 52.5(28–81) 54(21–75)
Sex (M/F) 7/0 7/3 14/3 21/13
Site of involvement
Lacrimal and salivary glands (LSG) 2/7(28.6) 1/10(10.0) 3/17(17.6) 21/34(61.8) 0.0065
 Lymph node 1/7(14.3) 5/10(50.0) 6/17(35.3) 20/34(58.8) 0.1441
 Pancreas 1/7(14.3) 0/10(0.0) 1/17(5.9) 8/34(23.5) 0.2412
 Liver 1/7(14.3) 0/10(0.0) 1/17(5.9) 1/34(2.9) > 0.9999
 Endocranium, dura mater, sellar region 5/7(71.4) 1/10(10.0) 6/17(35.5) 1/34(2.9) 0.0038
 Retroperitoneum 0/7(0.0) 0/10(0.0) 0/17(0.0) 4/34(11.8) 0.2876
 Skin 1/7(14.3) 1/10(10.0) 2/17(11.8) 1/34(2.9) 0.5420
  1. M, male; F, female
  2. aMann–Whitney test between RDD total and IgG4-RD. RDD total group includes all the patients in RDD mimic IgG4-RD group and RDD group